search
Back to results

Muscle Oxygenation in Effort in Neuromuscular Diseases (OXYNEMU)

Primary Purpose

Neuromuscular Diseases

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
muscle oxygenation
Sponsored by
University Hospital, Lille
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Neuromuscular Diseases focused on measuring Becker muscular dystrophy, Facioscapulohumeral dystrophy, congenital myopathy, motor neurone diseases

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • healthy subjects and
  • subjects affected by one of the fallowing neuromuscular diseases: Becker Muscular dystrophy Facioscapulohumeral dystrophy, Limb Girdle Muscular Dystrophy , Congenital Myopathy , Spinal Muscular Atrophy Charcot Marie Tooth Disease and Amyotrophic Lateral Sclerosis ,
  • able to walk
  • presenting a manual muscle testing of at Least 4/5 on the quadriceps according to the Medical research Council

Exclusion Criteria:

  • musculoskeletal pain of the quadriceps
  • other neurological disorders
  • Heart failure arrhythmia, uncontrolled hypertension, angina pectoris
  • dyspnoea >2 according to the NYHA
  • Peripheral artery disease
  • BMI >30kg.m-2.

Sites / Locations

  • Hôpital Amiens Nord, Service de Neurologie
  • CHRU de Lille, Hôpital SwyngedhauwRecruiting
  • Hôpital Sébastopol, CHU de Reims

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

muscle oxygenation

Arm Description

assesment of muscle oxygenation and gas exchanges

Outcomes

Primary Outcome Measures

muscle oxygenation
level of deoxyhemoglobin assessed with the NIRS device during the isokinetic effort of the knee extensors
Muscle oxygenation
kinetics of the deoxyhemoglobin assessed with the NIRS device during the isokinetic effort of the knee extensors

Secondary Outcome Measures

maximal isokinetic strength of the knee extensors
measurements of the maximal moment during a maximal effort of the knee extensors with an isokinetic dynamometer
Gas exchange
measurements of O2 and CO2 exchanges during the isokinetic effort
MFM score
Motor Function Measure score (in %) assessment. quantitative scale that makes it possible to measure the functional motor abilities of a person affected by a neuromuscular disease.
6 Minutes Walking Test (MWT)
assessment of the time performed during a 6 minutes walking test
Vignos functional scales
assesment of the 1 to 6 Vignos score for the lower limb functional assesment
Brooke functional scales
the 1 to 10 Brooke score for upper limb functional assesment
Medical Research Council Muscle testing
Assesment of the Medical Research Council 1 to 5 Muscle testing score of the quadriceps muscles
Mitochondrial phenotype
Mitochondrial respiration (O2 consumption) of muscle fibers of the vastus lateralis
Mitochondrial H2O2 production
Mitochondrial H2O2 production of muscle fibers of the vastus lateralis
kinetic of Muscle oxygenation
kinetic of level of deoxyhemoglobin during the isokinetic effort of the extensors of the knee

Full Information

First Posted
May 24, 2016
Last Updated
May 18, 2017
Sponsor
University Hospital, Lille
search

1. Study Identification

Unique Protocol Identification Number
NCT02789059
Brief Title
Muscle Oxygenation in Effort in Neuromuscular Diseases
Acronym
OXYNEMU
Official Title
Muscle Oxygenation Modification During Effort in 4 Groups of Neuromuscular Diseases Compared to Healthy Controls, and Mitochondrial Function and Phenotype Assessment
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Unknown status
Study Start Date
July 2, 2015 (Actual)
Primary Completion Date
July 2017 (Anticipated)
Study Completion Date
July 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Lille

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Previous studies showed modifications of muscle oxygenation parameters in muscular dystrophies du to an impairment or an absence of dystrophin. Our study aim at assessing muscle oxygenation during effort in different neuromuscular diseases (muscular dystrophies related and not related to dystrophin, non dystrophic myopathies and motor neuron diseases) compared to a group of healthy controls. Patients and controls are invited to perform an inframaximal , standardized effort of the knee extensors by the mean of an isokinetic dynamometer. Muscle oxygenation parameters are assessed through a Near Infrared Spectroscopy (NIRS) Device. In patients affected by dystrophin related myopathies, a muscle biopsy will be performed in order to analyse mitochondrial oxygenation parameters and mitochondrial phenotype. Our Hypothesis is that muscle oxygenation is impaired in dystrophin related muscular dystrophies compared to other neuromuscular diseases and healthy controls because of lack of muscle capillary vessels dilatation during effort and impairment of mitochondrial function.
Detailed Description
This study is a prospective physiological study in a pathological condition (neuromuscular diseases). 5 groups of voluntary participants will be investigated: 1. 20 subjects affected by Dystrophin related muscular dystrophy (Becker Muscular Dystrophy ) 2. Subjects affected by muscular dystrophy not related to dystrophin impairment : 20 subjects affected by facioscapulohumeral dystrophy and 20 subjects affected by Limb Girdle Muscular dystrophy 3. 20 subjects affected by non-dystrophic myopathies (Congenital myopathies ) 4. 20 subjects affected by motor diseases: amyotrophic lateral sclerosis(ALS), Charcot Marie Tooth disease, Spinal Muscular Atrophy . 5. 20 healthy controls Objective: asses the muscular oxygenation modifications during a standardized effort and compare the variables between groups. Analyze the mitochondrial function and phenotype in the BMD group compared to healthy controls Outcome : Muscle Oxygenation by Near Infrared Spectroscopy parameters; oxygen consumption, Muscle Function Measure, Vignos and Brooke score, Borg scale, 6 minutes walk test, mitochondrial phenotype, mitochondrial oxygenation 3 visits : 1- inclusion 2- standardized effort protocol 3- for Becker dystrophy patients and voluntary controls, muscle biopsy of the Vastus Lateralis

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neuromuscular Diseases
Keywords
Becker muscular dystrophy, Facioscapulohumeral dystrophy, congenital myopathy, motor neurone diseases

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
170 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
muscle oxygenation
Arm Type
Experimental
Arm Description
assesment of muscle oxygenation and gas exchanges
Intervention Type
Other
Intervention Name(s)
muscle oxygenation
Other Intervention Name(s)
Muscle biopsy
Intervention Description
Subjects will be invited to perform an isokinetic effort of the knee extensors against an isokinetic dynamometer. During this effort, muscle oxygenation and oxygen consumption will be assessed with a near infrared spectroscopy device and a gas exchange measurement device. Patients affected by Becker muscular dystrophy and healthy controls will be invited to have a muscle biopsy of the vastus lateralis.
Primary Outcome Measure Information:
Title
muscle oxygenation
Description
level of deoxyhemoglobin assessed with the NIRS device during the isokinetic effort of the knee extensors
Time Frame
on the day of first evaluation Visit V1
Title
Muscle oxygenation
Description
kinetics of the deoxyhemoglobin assessed with the NIRS device during the isokinetic effort of the knee extensors
Time Frame
on the day of first evaluation Visit V1
Secondary Outcome Measure Information:
Title
maximal isokinetic strength of the knee extensors
Description
measurements of the maximal moment during a maximal effort of the knee extensors with an isokinetic dynamometer
Time Frame
on the day of first evaluation Visit V1
Title
Gas exchange
Description
measurements of O2 and CO2 exchanges during the isokinetic effort
Time Frame
on the day of first evaluation Visit V1
Title
MFM score
Description
Motor Function Measure score (in %) assessment. quantitative scale that makes it possible to measure the functional motor abilities of a person affected by a neuromuscular disease.
Time Frame
on the day of first evaluation Visit V1
Title
6 Minutes Walking Test (MWT)
Description
assessment of the time performed during a 6 minutes walking test
Time Frame
on the day of first evaluation Visit V1
Title
Vignos functional scales
Description
assesment of the 1 to 6 Vignos score for the lower limb functional assesment
Time Frame
on the day of first evaluation Visit V1
Title
Brooke functional scales
Description
the 1 to 10 Brooke score for upper limb functional assesment
Time Frame
on the day of first evaluation Visit V1
Title
Medical Research Council Muscle testing
Description
Assesment of the Medical Research Council 1 to 5 Muscle testing score of the quadriceps muscles
Time Frame
on the day of first evaluation Visit V1
Title
Mitochondrial phenotype
Description
Mitochondrial respiration (O2 consumption) of muscle fibers of the vastus lateralis
Time Frame
at V2 at least 1 week after V1
Title
Mitochondrial H2O2 production
Description
Mitochondrial H2O2 production of muscle fibers of the vastus lateralis
Time Frame
at V2 at least 1 week after V1
Title
kinetic of Muscle oxygenation
Description
kinetic of level of deoxyhemoglobin during the isokinetic effort of the extensors of the knee
Time Frame
on the day of first evaluation Visit V1

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: healthy subjects and subjects affected by one of the fallowing neuromuscular diseases: Becker Muscular dystrophy Facioscapulohumeral dystrophy, Limb Girdle Muscular Dystrophy , Congenital Myopathy , Spinal Muscular Atrophy Charcot Marie Tooth Disease and Amyotrophic Lateral Sclerosis , able to walk presenting a manual muscle testing of at Least 4/5 on the quadriceps according to the Medical research Council Exclusion Criteria: musculoskeletal pain of the quadriceps other neurological disorders Heart failure arrhythmia, uncontrolled hypertension, angina pectoris dyspnoea >2 according to the NYHA Peripheral artery disease BMI >30kg.m-2.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Vincent Tiffreau, MD
Email
vincent.tiffereau@CHRU-LILLE.FR
First Name & Middle Initial & Last Name or Official Title & Degree
Nicolas Olivier, PhD
Email
nicolas.olivier@univ-lille2.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vincent Tiffreau, MD
Organizational Affiliation
CHRU de LILLE
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital Amiens Nord, Service de Neurologie
City
Amiens
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Philippe MERLE, MD,PhD
Email
merle.philippe@chu-amiens.fr
First Name & Middle Initial & Last Name & Degree
Philippe MERLE, MD,PhD
Facility Name
CHRU de Lille, Hôpital Swyngedhauw
City
Lille
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vincent TIFFEREAU, MD
Email
vincent.tiffreau@chru-lille.fr
First Name & Middle Initial & Last Name & Degree
Vincent TIFFREAU, MD
First Name & Middle Initial & Last Name & Degree
Arnaud LACOUR, MD
Facility Name
Hôpital Sébastopol, CHU de Reims
City
Reims
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
François BOYER, MD,PhD
Email
fboyer@chu-reims.fr
First Name & Middle Initial & Last Name & Degree
François BOYER, MD,PhD

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
22683375
Citation
Allart E, Olivier N, Hovart H, Thevenon A, Tiffreau V. Evaluation of muscle oxygenation by near-infrared spectroscopy in patients with Becker muscular dystrophy. Neuromuscul Disord. 2012 Aug;22(8):720-7. doi: 10.1016/j.nmd.2012.04.011. Epub 2012 Jun 8.
Results Reference
background

Learn more about this trial

Muscle Oxygenation in Effort in Neuromuscular Diseases

We'll reach out to this number within 24 hrs